Boston Scientific Corp.
This article was originally published in The Gray Sheet
Executive SummaryTaps Paul LaViolette to head the firm's "international sales and marketing organization" as president of Boston Scientific International, the firm announces Jan. 7. LaViolette replaces Jerry Lacey, 59, who will remain involved with the firm to a lesser degree. LaViolette comes to Boston Scientific from Bard, where he was president of the USCI division ("The Gray Sheet" March 8, 1993, In Brief). LaViolette was not one of the defendants in Bard's recent plea agreement involving the USCI business
You may also be interested in...
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?